i
Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique
-
Dec 04 2015
Source: Reprod Health. 12.
Details:
-
Alternative Title:Reprod Health
-
Personal Author:
-
Description:Background
A major unresolved safety concern for malaria case management is the use of artemisinin combination therapies (ACTs) in the first trimester of pregnancy. There is a need for human data to inform policy makers and treatment guidelines on the safety of artemisinin combination therapies (ACT) when used during early pregnancy.
Methods
The overall goal of this paper is to describe the methods and implementation of a study aimed at developing surveillance systems for identifying exposures to antimalarials during early pregnancy and for monitoring pregnancy outcomes using health and demographic surveillance platforms.
Discussion
Despite few limitations, the methods described here are relevant to the development of sustainable pharmacovigilance systems for drugs used by pregnant women in the tropics using health and demographic surveillance sites to prospectively ascertain drug safety in early pregnancy.
Trial registration
NCT01232530
Electronic supplementary material
The online version of this article (doi:10.1186/s12978-015-0101-0) contains supplementary material, which is available to authorized users.
-
Subject:
-
Source:
-
Pubmed ID:26637464
-
Pubmed Central ID:PMC4670540
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
More +